Literature DB >> 25902478

Proteus mirabilis: The Enemy Within.

Amiran Dzutsev1, Giorgio Trinchieri2.   

Abstract

The organism needs to tailor the intestinal inflammatory response to pathogenic bacteria and to pathobionts that are only occasionally pathogenic. In this issue of Immunity, Seo et al. (2015) show that the pathobiont Proteus mirabilis induces NLRP3 inflammasome-dependent interleukin-1β (IL-1β) release from CCR2(+) Ly6C(high) inflammatory monocytes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25902478     DOI: 10.1016/j.immuni.2015.04.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  5 in total

1.  Gut immunoglobulin alpha anti-glycan binding profiles as a research tool for local disease detection.

Authors:  Joseph J Otto; Crystal L Daniels; Lindsay N Schambeau; Brittany N Williams; Jana M Rocker; Lewis K Pannell
Journal:  Glycoconj J       Date:  2018-06-09       Impact factor: 2.916

2.  IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer.

Authors:  Elena Voronov; Ron N Apte
Journal:  Cancer Microenviron       Date:  2015-12-19

3.  Proteus mirabilis Urease: Unsuspected Non-Enzymatic Properties Relevant to Pathogenicity.

Authors:  Matheus V C Grahl; Augusto F Uberti; Valquiria Broll; Paula Bacaicoa-Caruso; Evelin F Meirelles; Celia R Carlini
Journal:  Int J Mol Sci       Date:  2021-07-04       Impact factor: 5.923

4.  Antimicrobial Resistance Gene Prevalence in a Population of Patients with Advanced Dementia Is Related to Specific Pathobionts.

Authors:  Aislinn D Rowan-Nash; Rafael Araos; Erika M C D'Agata; Peter Belenky
Journal:  iScience       Date:  2020-02-13

5.  Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway.

Authors:  Qi Liu; Rui Zuo; Kai Wang; Fei-Fei Nong; Ya-Jun Fu; Shao-Wei Huang; Zeng-Feng Pan; Yi Zhang; Xia Luo; Xiang-Liang Deng; Xiao-Xue Zhang; Lian Zhou; Yang Chen
Journal:  Acta Pharmacol Sin       Date:  2020-01-14       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.